Opus Point Partners Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Opus Point Partners Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,689	Closed	-$361K	–	64
2017 Q4	$361K	Sell	6,689 -4,367	-39%	-$239K	0.31%	44
2017 Q3	$631K	Buy	+11,056	New	+$648K	0.57%	42
2017 Q2	–	Sell	-5,587	Closed	-$304K	–	74
2017 Q1	$304K	Buy	+5,587	New	+$275K	0.23%	64

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Opus Point Partners Management's BIVV Position: Q1 2018 in Review

Opus Point Partners Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 6,689 shares — an estimated $361K sold.

Opus Point Partners Management first reported a position in BIVV in Q1 2017 and held it in 3 quarters. The position peaked at $631K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Opus Point Partners Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Opus Point Partners Management sold 6,689 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $361K.
Opus Point Partners Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 3 quarters.
Opus Point Partners Management's Bioverativ Inc. Common Stock position peaked at $631K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Opus Point Partners Management's 13F filing for Q1 2018, filed 15 May 2018.